Newsroom

Categories: Pharma, Clinical Research & Trials, Corporate, Finance & Investor

Inceptua Group appoints healthcare industry leader Kurt Hilzinger as chairman of the board

February 23, 2026

Categories: Omics & Genetics, Clinical Research & Trials, Corporate, Finance & Investor

Cirena launches high-purity long RNA to accelerate CRISPR and genome-editing research

February 3, 2026

Categories: Microscopy & Imaging, Clinical Research & Trials, Corporate, Finance & Investor

Fidēs Imaging launches next-generation imaging core lab

January 29, 2026

Categories: Drug Discovery & Development, Clinical Research & Trials

Cycle Pharmaceuticals and Inceptua Group expand the Free Goods Programme for patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) to include Morocco and Egypt.

January 9, 2026

Categories: Healthcare, COVID-19, Clinical Research & Trials

Groundbreaking myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities

December 4, 2025

Categories: Biomanufacturing, Clinical Research & Trials

Lonza expands its TheraPEAK® product portfolio with the addition of AmpliCell® Cytokine range and TheraPEAK® 293-GT® Medium

October 6, 2025

Categories: Omics & Genetics, Biotechnology, Drug Discovery & Development, Pharma, Clinical Research & Trials

EpiCypher launches Fiber-seq, a breakthrough multiomic single-molecule genomics assay

September 3, 2025

Categories: Pharma, Clinical Research & Trials

Friends of Cancer Research and MMS collaborate to develop decision frameworks for interim overall survival data in oncology trials

August 20, 2025

Categories: Healthcare, Clinical Research & Trials

Duke Street Bio receives FDA Fast Track designation for PARP1-Selective Inhibitor DSB2455 in patients with HRD brain metastases from triple-negative breast cancer

June 16, 2025